ArticleJournal for immunotherapy of cancer2020
Tocilizumab, but not dexamethasone, prevents CRS without affecting antitumor activity of bispecific antibodies.
Joseph Kauer et al.PubMed ↗Full text ↗Publisher ↗
No numbers read from the abstract.
39 papers cite it
this paperpooled ittrialcites it